Cargando…
Treat-to-Target in Axial Spondyloarthritis: Are we there yet?
The Treat-to-target (T2T) strategy in axial spondyloarthritis (axSpA) stipulates that treatment should reach a predefined target and if not reached, intensification of therapy is implemented aiming at best future outcomes. Clinical remission was recommended by the 2017 international task force as th...
Autores principales: | Aouad, Krystel, El-Zorkany, Bassel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450186/ https://www.ncbi.nlm.nih.gov/pubmed/36127927 http://dx.doi.org/10.31138/mjr.33.1.137 |
Ejemplares similares
-
The treatment journey for patients with axial spondyloarthritis in North Africa and the Middle East: From diagnosis to management
por: El Zorkany, Bassel, et al.
Publicado: (2020) -
Prevalence and consequences of psoriasis in recent axial spondyloarthritis: an analysis of the DESIR cohort over 6 years
por: Lucasson, Florian, et al.
Publicado: (2022) -
Go or no-go for treat-to-target in axial spondyloarthritis?
por: Webers, Casper, et al.
Publicado: (2023) -
Coxitis in axial spondyloarthritis: the unmeasured, yet functionally most important, radiographic progression
por: Rocha, Francisco Airton Castro, et al.
Publicado: (2021) -
Treat-to-target in axial spondyloarthritis: an observational study in daily practice
por: Beckers, Esther, et al.
Publicado: (2021)